A Young Disease: A Holistic Approach to the Treatment of Antiphospholipid Syndrome
Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?
Improving Bone Mineral Density: Risedronate vs. Denosumab
How Do Reduced-Dose Glucocorticoids Plus Rituximab Affect ANCA-Associated Vasculitis?
FDA’s Arthritis Advisory Committee Narrowly Endorses Avacopan Approval
Efficacy of Tocilizumab Monotherapy After Ultra-Short Glucocorticoid Administration in GCA
Study: Can Avacopan Replace Steroids in ANCA-Associated Vasculitis?
Denosumab Has Edge on Alendronate for Steroid-Induced Bone Loss
A Year to Remember: Dr. Jinoos Yazdany Presents the 2020 Clinical Research Review
- 1
- 2
- 3
- 4
- Next Page »